| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/04/2007 | CN1939412A Medicinal composition with dauricine and houttuynin sodium |
| 04/04/2007 | CN1939365A Cell-repairing oral liquid |
| 04/04/2007 | CN1939351A Method for inspecting lucid ganoderma product quality |
| 04/04/2007 | CN1939336A Pharmaceutical agent containing hyaluronan as an active ingredient |
| 04/04/2007 | CN1939335A Cancer therapy using whole glucan particles and antibodies |
| 04/04/2007 | CN1939334A Freeze-drying powder for injecting lentinan and its content determination |
| 04/04/2007 | CN1939332A Medical usage of S-adenyhomotype cysteine |
| 04/04/2007 | CN1939324A Medical usage of periplocin A and E |
| 04/04/2007 | CN1939319A Isoglycyrrhiza acid magnesium externally-applied preparation, its making method and usage |
| 04/04/2007 | CN1939318A Isoglycyrrhiza acid magnesium oral preparation and its making method |
| 04/04/2007 | CN1939317A Isoglycyrrhiza acid magnesium preparation for vein and its making method |
| 04/04/2007 | CN1939302A Siromosi medicinal composition and its making method |
| 04/04/2007 | CN1939296A Theapolyphenol composition and its preparation |
| 04/04/2007 | CN1939295A Baical skullcap root dropping balls and making method thereof |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308447C Degraded agonist antibody |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/04/2007 | CN1308038C Novel combination of glucocorticoids and PDG-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD |
| 04/04/2007 | CN1308037C FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 04/04/2007 | CN1308034C Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid |
| 04/04/2007 | CN1308016C Tonic wine |
| 04/04/2007 | CN1308011C Method for extracting ganoderma lucidum spore fat soluble active substance |
| 04/04/2007 | CN1308010C Method for extracting active component of radix scutellariae |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307991C Benzopyrany/derivatives and antiallergic agent |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199131 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce interferon-alpha biosynthesis or as a viricide or anticarcinogenic agent |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198909 Myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 04/03/2007 | US7198800 spray on skin patch drug delivery system; substantially water insoluble film forming agent; film plasticiser agent; water soluble compound; and organic solvent |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2210152C Green porphyrins as immunomodulators |
| 04/03/2007 | CA2193365C Polynucleotide vaccine for papillomavirus |
| 04/03/2007 | CA2181006C N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 04/03/2007 | CA2180660C Novel piperidine derivatives with paf antagonist activity |
| 03/29/2007 | WO2007035703A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist |
| 03/29/2007 | WO2007035191A1 Use of interferon tau for treating il-10 deficiency |
| 03/29/2007 | WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034748A1 Immunomodulating agent in gut |
| 03/29/2007 | WO2007034325A1 Carboxamide derivatives as muscarinic receptor antagonists |
| 03/29/2007 | WO2007034253A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 03/29/2007 | WO2007034173A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/29/2007 | WO2007033475A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
| 03/29/2007 | WO2007010406A3 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 03/29/2007 | US20070072893 Substituted imidazo ring systems and methods |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/29/2007 | US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
| 03/29/2007 | US20070071765 Compositions for Immunotherapy and Uses Thereof |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071722 Nucleotide vaccine composition |
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | CA2623304A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2623153A1 The use of sirnas in organ storage/reperfusion solutions |
| 03/29/2007 | CA2623025A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof |
| 03/28/2007 | EP1767626A1 Peroral vaccine carrier system |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767216A1 Drug having regulatory cell ligand contained in liposome |
| 03/28/2007 | EP1767214A1 Use of neurotrophil activating protein of helicobacter pylori (HP-NAP) and/or of its portions as adjuvants for the development of T helper type 1 (TH1) immune responses |
| 03/28/2007 | EP1767211A1 Pharmaceutical agent containing hyaluronan as an active ingredient |
| 03/28/2007 | EP1767200A1 Antiaging agent |
| 03/28/2007 | EP1767193A2 Pharmaceutical compositions |
| 03/28/2007 | EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 03/28/2007 | EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 03/28/2007 | EP1765412A2 Multivalent vla-4 antagonists comprising polyethylene glycol moieties |
| 03/28/2007 | EP1765395A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 03/28/2007 | EP1765391A1 Bacterial compositions for the treatment of cancer |
| 03/28/2007 | EP1765382A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 03/28/2007 | EP1765320A2 Use of ppar agonists to treat ruminants |
| 03/28/2007 | EP1765313A2 Compounds for immunopotentiation |